Status:
COMPLETED
The Effects of Gabapentin Premedication on Neurosurgery
Lead Sponsor:
Capital Medical University
Conditions:
Cerebral Tumor
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study is to observe the effects of gabapentin premedication on postoperative pain,vomiting and nausea in patients undergoing neurosurgery. 100 neurosurgical patients are randomized into groups gab...
Detailed Description
This is a random, double-blind study. In GG, patients are given gabapentin 600mg orally at the night and 2hours before surgery, respectively. In PG, vitamine pills are given instead.Total intravenous ...
Eligibility Criteria
Inclusion
- 18-65 years old, ASA physical status I or II, BMI\<30
- Scheduled for elective craniotomy
- Cooperative and given informed consent in person
Exclusion
- History of mental or psychiatric disorders
- Pregnant or lactating female
- History of systemic malignant tumor or diabetes
- Previously treated with this protocol or participated in another experimental study within previous 30 days
- Suspected history of allergic reaction or intolerance to gabapentin or other anesthetic agents in this study
- History of alcohol abuse and/or drug abuse within previous one year
Key Trial Info
Start Date :
December 14 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT02306278
Start Date
December 14 2014
End Date
June 1 2016
Last Update
October 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology,Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100050